A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use

Hepatology

Volumn 29, Issue 2, 1999, Pages 590-596

  Inglesby, Thomas V ^a   Rai, Rudra ^a   Astemborski, Jacquie ^b   Gruskin, Leslie ^b   Nelson, Kenrad E ^b   Vlahov, David ^a,b   Thomas, David L ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS INFECTIVITY;

ADULT; ALANINE TRANSAMINASE; BIOPSY; COMMUNITY HEALTH SERVICES; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER; MALE; PROSPECTIVE STUDIES; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0033030128     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290219     Document Type: Article

References (11)

1. Alter MJ. Epidemiology of hepatitis C. HEPATOLOGY 1997;26:62S-65S.
2. World Health Organization. Hepatitis C: global prevalence. Wkly Epidemiol Rec 1997;72:341-348.
3. Carithers RL Jr., Emerson SS. Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials. HEPATOLOGY 1997;26:83S-88S.
4. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. HEPATOLOGY 1997;26:15S-20S.
5. Seeff LB. Natural history of hepatitis C. HEPATOLOGY 1997;26:21S-28S.
6. Davis GL, Lau JYN. Factors predictive of a beneficial response to therapy of hepatitis C. HEPATOLOGY 1997;26:122S-127S.
7. Marcellin P, Levy S, Erlinger S. Therapy of hepatitis C: patients with normal aminotransferase levels. HEPATOLOGY 1997;26:133S-136S.
8. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-1905.
9. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, Purcell RH. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991;325:98-104.
10. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991:14:969-974.
11. Van Thiel D, Caraceni P, Molloy PJ, Hassanein T, Kania RJ, Gurakar A, Friedlander L. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy. J Hepatol 1995;23:503-508.